Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSG | P08311 | 4/20 | 0.93 |
| ▸ | CMA1 | P23946 | 4/20 | 0.93 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 9/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2123194 | 0.97 | CTSG (1.00) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| Water SCHEMBL3536654 | 0.96 | CTSG (0.98) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| Hydrochloric Acid SCHEMBL5117973 | 0.96 | CTSG (0.98) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| Alcohol SCHEMBL3541187 | 0.94 | CTSG (0.95) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| Sulfuric Acid SCHEMBL5126368 | 0.93 | CTSG (0.93) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| SCHEMBL5118065 | 0.92 | CTSG (0.92) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| Propanol SCHEMBL3540341 | 0.92 | CTSG (0.92) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| SCHEMBL5119379 | 0.87 | CTSG (0.82) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| SCHEMBL5621539 | 0.87 | CTSG (0.82) | CTSGCMA1L3MBTL1PTGDR2PDPK1 | |
| SCHEMBL5622365 | 0.86 | CTSG (0.81) | CTSGCMA1L3MBTL1PTGDR2PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7649008-B2 | Crystal of benzimidazole derivative and process for producing the same | TEIJIN PHARMA LIMITED (JP) | 2010-01-19 | — | — | US | claimed |
| US-20060293375-A1 | Crystal of benzimidazole derivative and process for producing the same | TEIJIN PHARMA LIMITED | 2006-12-28 | — | — | US | claimed |
| EP-1626048-A1 | CRYSTAL OF BENZIMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | Teijin Pharma Limited (JP) | 2006-02-15 | — | — | EP | claimed |
| US-7649008-B2 | Crystal of benzimidazole derivative and process for producing the same | TEIJIN PHARMA LIMITED (JP) | 2010-01-19 | — | — | US | disclosed |
| US-20060293375-A1 | Crystal of benzimidazole derivative and process for producing the same | TEIJIN PHARMA LIMITED | 2006-12-28 | — | — | US | disclosed |
| EP-1626048-A1 | CRYSTAL OF BENZIMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | Teijin Pharma Limited (JP) | 2006-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293375-A1 | Crystal of benzimidazole derivative and process for producing the same | ABAT, DBI, BRI3BP | CTSG 4148/4885CMA1 1635/4885L3MBTL1 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.